# The Molecular and Cellular Basis of Physiological Changes in Pregnancy and Its Implications in Neurologic and Ophthalmic Pathologies

**Authors:** Yi-Ting Chiang, Jie-Hong Chen, Kuo-Hu Chen

PMC · DOI: 10.3390/ijms26115220 · 2025-05-29

## TL;DR

Pregnancy causes significant brain and body changes that support motherhood but can also lead to neurological and eye-related health issues.

## Contribution

This review systematically explores how pregnancy-induced physiological changes contribute to neurologic and ophthalmic pathologies.

## Key findings

- Pregnancy leads to structural brain changes like gray matter reduction and white matter reorganization.
- Hormonal fluctuations during pregnancy modulate neuroplasticity and maternal behavior.
- Pregnancy-related changes can predispose individuals to conditions like stroke, idiopathic intracranial hypertension, and preeclampsia-associated visual disturbances.

## Abstract

Pregnancy orchestrates profound neurological, hormonal, and anatomical transformations in the maternal brain, preparing it for caregiving and infant bonding. Neuroimaging reveals structural changes such as gray matter reductions and white matter reorganization during pregnancy, followed by partial recovery postpartum. These adaptations are modulated by fluctuating levels of estradiol, progesterone, prolactin, and oxytocin, which coordinate neuroplasticity and behavioral readiness. At the molecular and cellular levels, pregnancy hormones drive synaptic remodeling, neurogenesis, and glial activity. Together, these changes support maternal motivation, attachment, and responsiveness, highlighting the maternal brain’s dynamic plasticity across gestation and the postpartum period. Also, pregnancy induces profound physiological changes, particularly in vascular, hormonal, and neurologic systems, to support maternal and fetal health. While these adaptations are essential, they can predispose pregnant individuals to various neurologic and ophthalmic pathologies. This review explores how pregnancy-related changes—including hypercoagulability, pituitary enlargement, hormonal fluctuations, and immunological modulation—contribute to conditions such as stroke, idiopathic intracranial hypertension, preeclampsia-associated visual disturbances, and demyelinating disorders like neuromyelitis optica spectrum disorder and multiple sclerosis. Additionally, ocular manifestations of systemic diseases like diabetic retinopathy and thyroid orbitopathy are discussed. Understanding these complex interactions is critical for prompt recognition, accurate diagnosis, and appropriate management of vision-threatening and neurologically significant complications during pregnancy. Nevertheless, many aspects of physiological and pathological changes during and after pregnancy remain unknown and warrant further investigation.

## Linked entities

- **Chemicals:** estradiol (PubChem CID 450), progesterone (PubChem CID 5994), prolactin (PubChem CID 168266256), oxytocin (PubChem CID 439302)
- **Diseases:** stroke (MONDO:0005098), idiopathic intracranial hypertension (MONDO:0009468), preeclampsia (MONDO:0005081), neuromyelitis optica spectrum disorder (MONDO:0019100), multiple sclerosis (MONDO:0005301), diabetic retinopathy (MONDO:0005266)

## Full-text entities

- **Genes:** PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}
- **Diseases:** multiple sclerosis (MESH:D009103), diabetic retinopathy (MESH:D003930), systemic diseases (MESH:D034721), thyroid orbitopathy (MESH:D049970), preeclampsia (MESH:D011225), visual disturbances (MESH:D014786), stroke (MESH:D020521), idiopathic intracranial hypertension (MESH:D011559), neuromyelitis optica spectrum disorder (MESH:D009471), demyelinating disorders (MESH:D003711)
- **Chemicals:** estradiol (MESH:D004958), progesterone (MESH:D011374)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12154306/full.md

---
Source: https://tomesphere.com/paper/PMC12154306